Criterios y pautas de terapia combinada en la diabetes tipo 2

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Endocrinología y Nutrición

• Publication date

  2001-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S1575-0922(01)73510-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION

  2000cited by this paper
• Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study

  2000cited by this paper
• Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

  1999cited by this paper
• Efficacy of metformin in the treatment of NIDDM. Meta-analysis.

  1999cited by this paper
• Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

  1999cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Pharmacologic Therapy for Type 2 Diabetes Mellitus

  1999cited by this paper
• Repaglinide versus glyburide: a one-year comparison trial.

  1999cited by this paper
• Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus

  1999cited by this paper
• Asociación de insulina y metformina en pacientes obesos con diabetes mellitus tipo 2

  1999cited by this paper
• A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

  1999cited by this paper
• Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus

  1999cited by this paper
• Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49)

  1999cited by this paper
• Troglitazone: a review of its use in the management of type 2 diabetes mellitus.

  1999cited by this paper
• Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.

  1998cited by this paper
• Hepatic dysfunction associated with troglitazone.

  1998cited by this paper
• Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?

  1998cited by this paper
• Triple oral antidiabetic therapy.

  1998cited by this paper
• Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)

  1998cited by this paper
• UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 Diabetes

  1998cited by this paper
• Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

  1998cited by this paper
• Repaglinide – prandial glucose regulator: a new class of oral antidiabetic drugs

  1998cited by this paper
• Metformin and Lactic Acidosis: Guilt by association?

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Troglitazone Use in Insulin-Treated Type 2 Diabetic Patients

  1998cited by this paper
• Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.

  1998cited by this paper
• Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin Alone

  1998cited by this paper
• Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes

  1998cited by this paper
• Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.

  1998cited by this paper
• Adding metformin versus insulin dose increase in insulin‐treated but poorly controlled Type 2 diabetes mellitus: an open‐label randomized trial

  1998cited by this paper
• Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

  1998cited by this paper
• Long‐term effectiveness of a new α‐glucosidase inhibitor (BAY m1099‐miglitol) in insulin‐treated Type 2 diabetes mellitus

  1998cited by this paper
• Metformin: A review of its metabolic effects

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Efficacy and Safety of Acarbose in Insulin-Treated Patients With Type 2 Diabetes

  1998cited by this paper
• Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes

  1997cited by this paper
• Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

  1997cited by this paper
• Short-Term Comparison of Once- versus Twice-Daily Administration of Glimepiride in Patients with Non-Insulin-Dependent Diabetes Mellitus

  1997cited by this paper
• Outcome of metformin-facilitated reinitiation of oral diabetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

  1997cited by this paper
• The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone

  1997cited by this paper
• A Dose-Response Study of Glimepiride in Patients With NIDDM Who Have Previously Received Sulfonylurea Agents

  1996cited by this paper
• Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

  1996cited by this paper
• Glimepiride, a New Once-Daily Sulfonylurea: A double-blind placebo-controlled study of NIDDM patients

  1996cited by this paper
• Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.

  1996cited by this paper
• A Comparison of Acarbose Versus Metformin as an Adjuvant Therapy in Sulfonylurea-Treated NIDDM Patients

  1996cited by this paper
• Effect of Combination Therapy of Troglitazone and Sulphonylureas in Patients with Type 2 Diabetes Who Were Poorly Controlled by Sulphonylurea Therapy Alone

  1996cited by this paper
• United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus

  1996cited by this paper
• Long-Term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl®): A Double-Blind Comparison with Glibenclamide

  1996cited by this paper
• Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM

  1995cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper
• Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

  1995cited by this paper
• Comparison of Insulin With or Without Continuation of Oral Hypoglycemic Agents in the Treatment of Secondary Failure in NIDDM Patients

  1995cited by this paper
• Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study

  1995cited by this paper
• A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes

  1995cited by this paper
• The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus

  1994cited by this paper
• Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study

  1994cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

  1994cited by this paper
• Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen Study

  1994cited by this paper
• Therapy for Diabetes Mellitus and Related Disorders

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Comparison of Combined Therapies in Treatment of Secondary Failure to Glyburide

  1992cited by this paper
• Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysis

  1992cited by this paper
• Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.

  1992cited by this paper
• Insulin plus a sulfonylurea agent for treating type 2 diabetes.

  1991cited by this paper
• Efficacy of Bedtime NPH Insulin With Daytime Sulfonylurea for Subpopulation of Type II Diabetic Subjects

  1989cited by this paper
• Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial.

  1987cited by this paper
• Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

  1984cited by this paper
• Study Group

  1971cited by this paper

• Treatment of Diabetes Mellitus: General Goals and Clinical Practice Management

  2022cites this paper
• Síndrome de secreción inadecuada de hormona antidiurética por tratamiento con

  2016cites this paper
• Neuropatía diabética periférica: eficacia clínica de la evaluación Semiológica

  2015cites this paper
• Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain

  2013cites this paper
• Efecto hipoglicemiante del extracto acuoso de las hojas de Smallanthus sonchifolius (Yacón) en pacientes con diabetes mellitus tipo 2

  2012cites this paper
• Influencia de la telemedicina en el control del paciente diabético tipo 2

  2011cites this paper
• Guías actuales de práctica clínica en la diabetes mellitus tipo 2: ¿cómo aplicarlas en atención primaria?

  2010cites this paper
• Limitaciones y necesidades de mejora en el tratamiento de la diabetes mellitus. Perspectiva de atención primaria

  2007cites this paper
• Síndrome metabólico en los pacientes diabéticos de un centro de salud

  2007cites this paper
• Revisión de conocimientos sobre cuidados a pacientes con problemas endocrinometabólicos

  2007cites this paper
• Morbimortalidad por Diabetes Mellitus

  2006cites this paper
• Cumplimiento de los objetivos de control metabólico en diabetes mellitus en el medio rural de Ourense

  2006cites this paper
• Síndrome de secreción inadecuada de hormona antidiurética por tratamiento con clorpropamida

  2006cites this paper
• Grado de satisfacción de los profesionales de Atención Primaria con un modelo de actividad especializada basado en la consultoría

  2005cites this paper
• Manejo del paciente diabético hospitalizado

  2005cites this paper
• Perfil de los pacientes con diabetes mellitus tipo 2, en la Atención Primaria española

  2004cites this paper
• Tratamiento de la diabetes mellitus: objetivos generales y manejo en la práctica clínica

  2002cites this paper
• [Treatment of diabetes mellitus: general goals, and clinical practice management].

  2002cites this paper
• La terapia combinada en la diabetes mellitus tipo 2

  2002cites this paper
• Importancia de la atención primaria en el diagnóstico precoz de la apendicitis aguda y su repercusión en la población de Segovia. Aproximación a dicha patología

  2001cites this paper
• Algunas consideraciones sobre el Consenso de la Sociedad Española de Diabetes y de la Sociedad Española de Medicina Familiar y Comunitaria sobre los criterios y pautas de terapia combinada en la diabetes tipo 2

  2001cites this paper